Prescription drug · ANDA
Ivermectin NDC 75907-167
Ivermectin 3 mg/1 · Tablet · Oral · DR. REDDY'S LABORATORIES, INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 75907-167-21 | 75907016721 | 2 BLISTER PACK in 1 CARTON (75907-167-21) / 10 TABLET in 1 BLISTER PACKMarketed from Nov 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ivermectin
- Generic name (nonproprietary)
- ivermectin
- Active ingredients
- Ivermectin — 3 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218324
- Marketing start
- Listing expires
- Identifiers
- Product ID 75907-167_d1f547db-1cd1-4ff8-9549-edf1866e319cSPL ID d1f547db-1cd1-4ff8-9549-edf1866e319cSPL set ID 4cb062d7-0597-4e92-b2f6-7129a95e9500RxCUI 311207UNII 8883YP2R6D
- Pharmacologic class
- Antiparasitic; Pediculicide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N475907016721followed by a unit qualifier and the quantityPackage 75907-0167-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ivermectin is indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract Ivermectin is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis . This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin. (See CLINICAL PHARMACOLOGY, Clinical Studies ). Onchocerciasis Ivermectin is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus . This indication is based on randomized, double-bli…
Excerpt only. Read the full label for complete information.